Skip to main content
. 2023 Aug 28;13:1240786. doi: 10.3389/fonc.2023.1240786

Table 2.

Consistency of P53 expression between preoperative biopsy and final pathology.

Preoperative biopsy Final pathology
Total (n=1186, overall agreement: 83.8%, kappa: 0.624)
P53wt P53abn Total
P53wt 718 (60.5%) 109 (9.2%) 827 (69.7%)
P53abn 83 (7.0%) 276 (23.3%) 359 (30.3)
Total 801 (67.5%) 385 (32.5%) 1186 (100%)
D&C or Pipelle biopsy (n=652, overall agreement: 79.4%, kappa: 0.539)
P53wt P53abn Total
P53wt 367 (56.3%) 76 (11.7%) 443 (67.9%)
P53abn 58 (8.9%) 151 (23.2%) 209 (32.1%)
Total 425 (65.2%) 227 (34.8%) 652 (100%)
Hysteroscopic biopsy (n=534, overall agreement: 89.1%, kappa: 0.735)
P53wt P53abn Total
P53wt 351 (65.7%) 33 (6.2%) 384 (71.9)
P53abn 25 (4.7%) 125 (23.4%) 150 (28.1%)
Total 376 (70.4%) 158 (29.6%) 534 (100%)

P53abn, P53 abnormality; P53wt, P53 wild-type.